Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Embecta Corp. - Common Stock (NQ: EMBC )

15.57 -0.30 (-1.89%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 428,768
Open 16.07
Bid (Size) 15.57 (32)
Ask (Size) 15.58 (12)
Prev. Close 15.87
Today's Range 15.42 - 16.09
52wk Range 9.925 - 23.75
Shares Outstanding N/A
Dividend Yield 3.85%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Insulin Device Maker Embecta Weighs Sale After 70% Share Decline Following Becton Dickinson Spin-Off
Embecta is exploring a potential sale after a nearly 70% drop in share price since its spin-off from Becton Dickinson. The company's U.S. business has struggled with the rise of GLP-1 drugs and... 
Via Benzinga
Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga

Performance

YTD
-18.35%
-18.35%
1 Month
+27.52%
+27.52%
3 Month
+49.71%
+49.71%
6 Month
-7.98%
-7.98%
1 Year
-26.87%
-26.87%

More News

Read More
IQVIA Posts Upbeat Earnings, Joins Terex, Reddit And Other Big Stocks Moving Higher On Monday
Via Benzinga
Earnings Preview For Embecta
Via Benzinga
Thursday Is Your Last Chance To Buy Embecta Before The Dividend Payout
Via Benzinga
embecta to Report Fiscal Third Quarter 2024 Financial Results
From Embecta Corp.
Via GlobeNewswire
Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday
Via Benzinga
embecta-sponsored Abstracts Presented at American Diabetes Association’s 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir
From Embecta Corp.
Via GlobeNewswire
Embecta: Q4 Earnings Insights
Via Benzinga
Earnings Preview: Embecta
Via Benzinga
Morgan Stanley Maintains Underweight Rating for Embecta: Here's What You Need To Know
Via Benzinga
Trade Winds Turning: 3 Stocks Poised to Gain from Biden’s China Tariffs
Via InvestorPlace
Topics World Trade
Exposures Tariff
Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
EMBC Stock Earnings: Embecta Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Spectrum Brands Posts Upbeat Results, Joins AerSale, Sinclair, ICU Medical And Other Big Stocks Moving Higher On Thursday
Via Benzinga
US Stocks Mixed; Jobless Claims Rise More Than Expected
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Earnings Scheduled For February 9, 2024
Via Benzinga
Sustaining Growth Momentum: Dentsply Sirona Continues to Excel and Reports Rising Profits
Via Benzinga
Earnings Scheduled For November 21, 2023
Via Benzinga
7 Contrarian Stocks to Buy for the High-Stakes Gambler
Via InvestorPlace
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Earnings Scheduled For May 12, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.